The GOF D374Y-PCSK9 causes a severe FH phenotype that is not readily reduced by statins.41 Carriers of this mutation are typically affected by CVD 10 years earlier than other FH patients. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.